Cobactan LC

Kraj: Nowa Zelandia

Język: angielski

Źródło: Ministry for Primary Industries

Składnik aktywny:

cefquinome sulphate

Dostępny od:

Schering-Plough Animal Health Limited

INN (International Nazwa):

cefquinome

Skład:

cefquinome sulphate 9.38 g/kg

Dziedzina terapeutyczna:

Antibiotic

Status autoryzacji:

ACVM Registered

Data autoryzacji:

2003-01-21

Charakterystyka produktu

COBACTAN LC
8 g – Leaflet, Carton and Label
A008116
Page 1 of 6
COBACTAN LC
10-Nov-22
Leaflet
RESTRICTED
VETERINARY
MEDICINE
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
COBACTAN
®
LC
Critically important antibiotic
PRESENTATION
An intramammary infusion in paraffin for rapid release and elimination
containing
9.375 MG/G CEFQUINOME (AS SULPHATE). One syringe contains 75 MG
CEFQUINOME.
Presented as a pack of 15 syringes and 15 teat wipes.
INDICATIONS
For the treatment of clinical mastitis in lactating cows caused by
_Staphylococcus _
_aureus, Streptococcus uberis, Streptococcus dysgalactiae, Escherichia
coli _and other
enterobacteria susceptible to cefquinome.
DOSAGE AND ADMINISTRATION
Milk out the affected quarter(s). After thoroughly cleaning and
disinfecting the teat and
teat orifice, infuse the contents of one syringe into each affected
quarter. Disperse the
product by gently massaging the teat and udder of the affected animal.
Treat the teat
canal of the infected quarter(s) every 12 hours, i.e. after each of 3
successive
milkings. Use each syringe for the treatment of only one teat.
CONTRAINDICATION
Not to be administered to animals which are known to be hypersensitive
to
cefquinome.
WITHHOLDING PERIODS
IT IS AN OFFENCE FOR USERS OF THIS PRODUCT TO CAUSE RESIDUES EXCEEDING
THE
RELEVANT MRL IN THE FOOD NOTICE: MAXIMUM RESIDUE LEVELS FOR
AGRICULTURAL
COMPOUNDS.
MEAT: Cattle producing meat or offal for human consumption must not be
sold for
slaughter either during treatment or within 2 days of the last
treatment.
MILK: Milk intended for sale for human consumption must be discarded
during
treatment and for not less than 8 milkings or approximately 96 hours
following the last
treatment.
HANDLING PRECAUTIONS
Penicillins and cephalosporins may cause hypersensitivity (allergy)
following injection, inhalation,
ingestion or skin contact. Hypersensitivity to penicillins may lead to
cross sensitivity to
cephalosporin and vice versa. Allergic reactions to these substances
may occasionally be serious.
1.
Do no